Selank TP-7 Research Peptide | Aqueous Selank Solution

$114.00

Selank TP-7 Research Peptide is a synthetic heptapeptide featuring the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is supplied as a pre-formulated aqueous solution for controlled laboratory research involving peptide characterization, stability, degradation, and molecular interaction studies.

Category:

Description

Selank TP-7 Research Peptide

Selank TP-7 Research Peptide is a synthetic heptapeptide composed of seven amino-acid residues. Its defined sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, and it is structurally associated with the tuftsin-derived peptide family. The reported molecular formula is C₃₃H₅₇N₁₁O₉, with a molecular weight of approximately 751.9 g/mol.

At LV Longevity Peptides, Selank TP-7 is positioned as a specialized research material for laboratories conducting controlled studies involving short-chain peptide structure, formulation behavior, stability, and analytical characterization.

Unlike a conventional lyophilized peptide vial, Selank TP-7 is supplied as an aqueous research solution. This distinction is important when evaluating the product’s analytical documentation, storage requirements, and finished-formulation characteristics.

Selank TP-7 Peptide Sequence

The defined Selank TP-7 sequence is:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

The peptide contains seven amino-acid residues and is commonly described as a synthetic analog of the naturally occurring peptide tuftsin. For technical accuracy, the product page should distinguish Selank TP-7 from other Selank derivatives, including N-acetylated or amidated analogs.

Selank TP-7 Research Applications

Selank TP-7 may be used in controlled laboratory environments for research involving:

  • Peptide sequence and structural characterization

  • Peptide stability and degradation studies

  • Enzymatic degradation pathway analysis

  • Analytical method development

  • Peptide binding and interaction investigations

  • Comparative studies of short-chain synthetic peptides

  • Research involving aqueous peptide formulations

  • Evaluation of formulation behavior under defined laboratory conditions

These descriptions refer exclusively to non-clinical research applications and should not be interpreted as claims of therapeutic performance.

Aqueous Selank Formulation

The liquid format of Selank TP-7 makes it different from isolated, lyophilized peptide material. A finished aqueous formulation may contain additional formulation components, such as excipients or stabilizing agents.

For this reason, the product page should emphasize:

  • Compound identity

  • Labeled peptide content

  • Finished-formulation assay

  • Formulation volume

  • Lot-specific analytical documentation

  • Appropriate storage and handling information

A single raw-material purity percentage should not automatically be used to describe the complete composition of a finished liquid formulation.

Technical Specifications

Specification

Selank TP-7

Product Name

Selank TP-7

Product Type

Synthetic research peptide

Peptide Class

Heptapeptide

Chemical Name

Selank

Sequence

Thr-Lys-Pro-Arg-Pro-Gly-Pro

Molecular Formula

C₃₃H₅₇N₁₁O₉

Molecular Weight

Approximately 751.9 g/mol

Physical Form

Aqueous solution

 

Chemical Information:
  • Chemical Name: Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro)
  • Molecular Formula: C33H57N11O9
  • Molecular Weight: 751.9 g/mol
  • Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
Molecular Structure:

 

Selank TP-7 aqueous research peptide formulation

Reviews

There are no reviews yet.

Be the first to review “Selank TP-7 Research Peptide | Aqueous Selank Solution”

Your email address will not be published. Required fields are marked *